Previous studies have shown that two types of virus-specific suppressor T cells (Ti) are induced in mice made tolerant with herpes simplex virus (HSV)-infected spleen cells (SC). One type of T. blocks the afferent phase of the delayed hypersensitivity response to HSV (T.-aff), and the other blocks the efferent or effector phase (Ts-eff). In this report we show that the induction requirements for these suppressor populations differ.
Studies over the past several years dealing with tolerance to delayed hypersensitivity (DH) responses have proved fruitful in elucidating how suppressor T cells (TJ) carry out their immunoregulatory functions. These studies have shown that T, responsible for the tolerant state can be induced not only by soluble antigen but by antigen-coupled lymphoid cells as well (1, 6, 21) . In most of these studies the coupled antigen has been a simple hapten. Recently, we have described the induction of tolerance mediated by Ts by using lymphoid cells coupled with a complex antigen, namely herpes simplex virus (HSV) (13) . Spleen cells (SC) infected with HSV when injected intravenously (i.v.) into mice were shown to induce tolerance in mice to an HSVspecific DH response (13) .
Tolerance of DH to HSV is mediated, at least in part, by two types of virus-specific Ts. Injection (i.v.) of soluble virus results in the induction of afferent-acting T, (Ts-aff), whereas i.v. injection of HSV-infected syngeneic SC induces T,-aff as well as efferent-acting Ts (Ts-eff) (13) . Both types of T, suppress the DH response to HSV, but they act on different limbs of the response. T,-aff block the early afferent phase of the DH response involving the induction and clonal expansion of DH-mediating T cells. T,-eff, on the other hand, act later in the efferent phase by blocking the expression of primed DH-mediating T cells (13) . Both T, are virus-specific in their action; i.e., T, raised in mice with HSV-induced tolerance did not affect the DH response to a different virus, vesicular stomatitis virus.
The finding that i.v. injection of soluble virus induced only the HSV-specific T,-aff population, whereas injection of SC treated in vitro with the same or similar virus preparation induced both HSV-specific T,-aff and T,-eff, suggested that the induction requirements for the populations differ significantly. In the present study we investigated and compared * Corresponding author.
the induction requirements for each T, population by using HSV-infected SC as tolerogen. Our results indicate that T,-aff are induced by SC which have passively adsorbed HSV-soluble proteins on their membrane. In contrast, Ts-eff appear to be induced only by SC which have been actively infected with HSV and express on their surface integral membrane proteins of viral origin. In addition, we show that T,-aff and T,-eff differ in their effector requirements for suppression of DH to HSV. The significance of these findings regarding Ts recognition and induction via cellassociated viral antigens is discussed.
MATERIALS AND METHODS
Mice. Five-week-old female BALB/c mice were purchased from Cumberland View Farms, Cumberland, Tenn. Virus. HSV type 1 (HSV-1) strain KOS Ts5 was used in all experiments. KOS Ts5 is a temperature-sensitive mutant which replicates normally at 34°C, but at the nonpermissive temperature of 39°C very little infectious virus is produced.
The procedure for growing virus in rabbit skin cells or mouse 3T6 cells (of BALB/c origin) has been described previously (12 into mice. In these experiments, the SC were infected with HSV-1 at an MOI of 10 to 20 (13) . To determine the minimum concentration of virus required to induce tolerance, SC were infected for 6 h with HSV-1 at different MOIs and then injected i.v. into normal recipients. Seven days later these mice were immunized with virus, and they were ear challenged 6 days after immunization. Significant tolerance was induced by HSV-SC irrespective of the dose of virus used to infect the cells (Table 1 , cf. groups B, C, and D). This suggested that the concentration of infectious virus particles was not the critical variable in producing tolerogenic HSV-SC. This conclusion is supported by the results shown in Table 1 for group E. Here, tolerance in mice was induced with SC which had been cultured for 6 h in the absence of virus, washed, suspended in the viral sonic extract at an MOI of 2, and immediately centrifuged. The DH response of this group was suppressed 79%, indicating that simple mixing of SC with viral sonic extract for a brief period is sufficient to render the SC tolerogenic. To explore this possibility, we treated SC with virus sonic extract which had been depleted of infectious virus by ultracentrifugation (see Materials and Methods). This supernatant contained less than 1% of the original input virus, and this residual virus accounted for an MOI of 0.02. After incubation with this virus-depleted supernatant, the SC were tested for their ability to induce T,-aff. SC treated with this virus-depleted supernatant were able to induce T,-aff in donor mice (Table 4) . Suppression of the ear swelling response in recipient mice was equivalent to that seen with T,-aff induced by SC treated with viral sonic extract which was not centrifuged (cf. groups B and C).
Although the ultracentrifuged supernatant still contained residual infectious virus, additional titration experiments have shown that Ts-aff are not induced with SC treated with an MOI of 0.05 or less (data not shown). Thus, it is unlikely that the contaminating virus particles were responsible for induction of the Ts-aff population. Furthermore, when supernatants of sonically treated material completely devoid of infectious virus particles (obtained by repeated ultracentrifugation of virus sonic extract) were used to treat SC, the T,-aff population was still induced (data not shown). T.-eff require a cyclophosphamide-sensitive cell in the immune recipient for suppressor function. Ts-eff in other suppressor cell systems have been shown to require a cyclophosphamide-sensitive T cell in the immune recipient for demonstration of suppression (15, (17) (18) (19) . This cyclophosphamide-sensitive T cell arises as a consequence of immunization and has been termed Ts-aux (18) or Ts-3 (15, 17, 19) . To determine whether Ts-aff or T,-eff in the HSV suppressor cell system require such a cyclophosphamide- Ts-aff induced by two forms of tolerogen were capable of suppressing the ear swelling response in cyclophosphamidepretreated recipients (Table 5 , experiments 1 and 2). In contrast, when Ts-eff were passively transferred into cyclophosphamide-pretreated recipients, no suppression of ear swelling occurred (experiment 3). This indicates that HSV-specific Ts-eff, like T,-eff in other antigen systems, act through a cyclophosphamide-sensitive cell in the immune recipient to mediate suppression of the DH response. HSVspecific Ts-aff do not require such a cell for suppression.
DISCUSSION
We showed previously that SC infected with HSV when injected i.v. into mice give rise to two types of suppressor cells, T,-aff and T,-eff, which suppress the DH response to HSV (13) . Both suppressor cells are T cells, and both are virus specific (i.e., the DH response to an unrelated virus is not inhibited) but not type specific for HSV-1 and HSV type 2 (13) . Aside from suppressing the DH response in either the afferent or efferent phase, very little was known which could distinguish the two populations of T,.
In this report we have characterized other differences between the two cell populations. Our initial approach involved studying the induction requirements of T,-aff and T,-eff by using different preparations of HSV-SC as tolerogen. Because the viral sonic extract used for preparing HSV-SC contained not only infectious viral particles but also soluble viral proteins and cellular and viral membrane fragments expressing viral antigens, it is unclear which of these components was responsible for T, induction. The experiments presented in this paper indicate that the two T, populations have different requirements for induction and that the various antigen components found in the viral sonic extract play a critical role in the induction process.
The major difference between the induction of the two T, populations is the requirement that SC be treated with infectious virus. T,-aff but not T,-eff are induced in mice which were made tolerant with SC treated with heatinactivated virus. Because infectious virus was not necessary, this suggested that the nonspecific adsorption of soluble viral proteins or antigenic membrane fragments onto SC might be responsible for induction of the Ts-aff population.
More direct evidence of induction by passively adsorbed viral antigens was obtained by using SC treated with soluble viral proteins prepared by separating sonically treated material over a sucrose gradient. These SC were able to induce Ts-aff as efficiently as SC treated with unseparated sonic extract. Thus, the ability of T,-aff to be induced by SC treated with heat-inactivated virus or supernatants depleted of infectious virus strongly suggests that passively adsorbed viral antigens are responsible for inducing this T, population.
Because of the enormous amount of structural and nonstructural proteins that are encoded by HSV-1, it would be difficult to determine which proteins in our infected sonic extract are adsorbing onto SC and inducing T,-aff. This problem can be approached by adsorbing purified HSV-1 glycoproteins on SC and determining whether tolerance and T. are induced by these SC. Our laboratory has shown that one such type-specific glycoprotein, glycoprotein C, was capable of inducing type-specific DH and protective immunity when used to immunize mice (14) . Preliminary experiments have shown that purified glycoprotein C is also capable of adsorbing onto SC and inducing tolerance against a glycoprotein C DH response. Whether Ts-aff is induced by glycoprotein C-treated SC is currently being investigated. Thus, the use of purified immunogenic HSV-1 glycoproteins may serve to determine whether envelope glycoproteins are capable of inducing T, when associated with SC, and if so, which ones are involved.
Compared with T,-aff, T,-eff had more stringent requirements for induction. This population required that the inducing SC be treated with infectious virus at the relatively high MOI of 10. This requirement appears rather stringent because SC infected with virus at an MOI of 5 or less did not give rise to the efferent-acting suppressor population. These results suggest that viral glycoproteins synthesized and inserted into the SC membrane as a consequence of viral infection are essential for induction of the Ts-eff population.
Superinfecting conditions may be required for the synthesis and expression of enough glycoproteins on infected SC, particularly if a specialized population of SC is involved in the induction process. Evidence for such a specialized cell has recently been obtained; HSV-infected plastic-adherent SC were able to induce Ts-eff, whereas the nonadherent fraction failed to do so (unpublished data). In other systems, specialized antigen-presenting cells for Ts are also plastic adherent as well as radioresistant and Ta positive (20) .
The question of whether cell-associated viral antigens arise via active infection or by passive adsorption takes on greater significance when the role of major histocompatibility complex restriction in Ts induction is considered. If Ts-eff induction involves recognition of nascent viral antigens on infected SC, such recognition may be in the context of class I major histocompatibility complex antigens. Similarly, Tsaff induction may involve recognition of adsorbed antigens which have been processed and presented with class II antigens on antigen-presenting cells. Preliminary experiments from our laboratory indicate that major histocompatibility complex restriction appears to be involved in the induction of both Ts populations. Neither population is induced when allogeneic HSV-SC are used as tolerogen. In contrast, when H-2 congenic combinations are used, major histocompatibility complex identity between inducing HSV-SC and recipient mice is sufficient for the induction of both cell populations. The nature of the restricting element(s) is currently being studied. Results from these experiments may reveal further differences between efferent and afferentacting Ts and may also elucidate some of the mechanisms of Ts induction.
Afferent and efferent Ts were also shown to differ in their effector requirements. Ts-eff did not suppress when transferred into cyclophosphamide-pretreated HSV-immune recipients, indicating that this Ts population requires a cyclophosphamide-sensitive target cell in the immune recipient to regulate the DH response to HSV. Ts-aff did not show such a requirement, i.e., significant suppression by Ts-aff was seen in both untreated and cyclophosphamide-treated recipients. This difference suggests that Ts-aff do not induce Ts-eff but rather that each population is capable of functioning independently. Cyclophosphamide-sensitive T cells in immune animals which interact with Ts-eff to down regulate DH responses have been described in other experimental systems. This cell has been termed T,-aux (18) or Ts-3 (15, 17, 19) and has the phenotype Thy 1+, Lyt 1-2+, I-J+ (15) . It should be noted that T,-aux and T,-3 described to date have all been induced by immunization with haptens, whereas our report of a T,-aux-and T,-3-like cell is, to our knowledge, the first involving regulation of immunity against an infectious agent.
Induction of tolerance and T, to viral antigens has been described in other laboratories. In most cases, i.v. injection of purified virus particles or viral sonic extracts was used as tolerogen. With reovirus, for example, i.v. administration of infectious virus induced DH, whereas UV-inactivated virus generated Ts (3) . The association of virus with antigenpresenting cells was postulated to be the determining factor as to whether immunity or suppression was induced. Nash et al. (8, 10) have also shown that i.v. injection of HSV sonic extract induces tolerance to DH in mice. In their system, UV-inactivated and Formalin-inactivated virus were both capable of inducing tolerance (10 
